miR-200c seems to be particularly important in breast cancer pathogenesis and response to treatment; for example, several authors indicated its role in cancer cell sensitivity to therapy, including trastuzumab use in HER2 positive breast cancer [87,88]. This evidence concerns the gene ERBB2 and breast carcinoma.